首页> 美国卫生研究院文献>Springer Open Choice >A two-step deconvolution-analysis-informed population pharmacodynamic modeling approach for drugs targeting pulsatile endogenous compounds
【2h】

A two-step deconvolution-analysis-informed population pharmacodynamic modeling approach for drugs targeting pulsatile endogenous compounds

机译:两步反卷积分析告知的群体药代动力学建模方法用于靶向搏动性内源性化合物的药物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pharmacodynamic modeling of pulsatile endogenous compounds (e.g. growth hormone [GH]) is currently limited to the identification of a low number of pulses. Commonly used pharmacodynamic models are not able to capture the complexity of pulsatile secretion and therefore non-compartmental analyses are performed to extract summary statistics (mean, AUC, Cmax). The aim of this study was to develop a new quantification method that deals with highly variable pulsatile data by using a deconvolution-analysis-informed population pharmacodynamic modeling approach. Pulse frequency and pulse times were obtained by deconvolution analysis of 24 h GH profiles. The estimated pulse times then informed a non-linear mixed effects population pharmacodynamic model in NONMEM V7.3. The population parameter estimates were used to perform simulations that show agonistic and antagonistic drug effects on the secretion of GH. Additionally, a clinical trial simulation shows the application of this method in the quantification of a hypothetical drug effect that inhibits GH secretion. The GH profiles were modeled using a turnover compartment in which the baseline secretion, kout, pulse secretion width, amount at time point 0 and pulse amplitude were estimated as population parameters. Population parameters were estimated with low relative standard errors (ranging from 2 to 5%). Total body water (%) was identified as a covariate for pulse amplitude, baseline secretion and the pulse secretion width following a power relationship. Simulations visualized multiple gradients of a hypothetical drug that influenced the endogenous secretion of GH. The established model was able to fit and quantify the highly variable individual 24 h GH profiles over time. This pharmacodynamic model can be used to quantify drug effects that target other endogenous pulsatile compounds.Electronic supplementary materialThe online version of this article (doi:10.1007/s10928-017-9526-0) contains supplementary material, which is available to authorized users.
机译:搏动性内源性化合物(例如生长激素[GH])的药效学建模目前仅限于少量脉冲的识别。常用的药效学模型无法捕获搏动性分泌物的复杂性,因此需要进行非隔室分析以提取汇总统计数据(平均值,AUC,Cmax)。这项研究的目的是开发一种新的量化方法,该方法通过使用去卷积分析信息化的总体药效学建模方法来处理高度可变的搏动数据。通过对24 h GH轮廓进行反卷积分析获得了脉冲频率和脉冲时间。然后,估计的脉冲时间通知了NONMEM V7.3中的非线性混合效应群体药效学模型。使用种群参数估计值进行模拟,以显示对GH分泌的激动和拮抗作用。另外,临床试验模拟显示了该方法在量化抑制GH分泌的假设药物作用中的应用。使用周转室对GH概况进行建模,其中基线分泌,kout,脉搏分泌宽度,在时间点0的量和脉搏振幅被估计为群体参数。总体参数的估计具有较低的相对标准误差(范围为2%到5%)。体内总水分(%)被确定为功率关系后脉搏振幅,基线分泌和脉搏分泌宽度的协变量。模拟显示了影响GH内源性分泌的假设药物的多个梯度。建立的模型能够随时间拟合并量化高度可变的个人24小时GH轮廓。该药效学模型可用于量化针对其他内源性搏动性化合物的药物作用。电子补充材料本文的在线版本(doi:10.1007 / s10928-017-9526-0)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号